2025
SJR Q1
JCR Q1 · 5,7
OA
30 matched articles
SCIE
Journal detail
Marine Drugs
- Publisher
- Multidisciplinary Digital Publishing Institute (MDPI)
- Country
- Switzerland · Western Europe
- Type
- journal
- ISSN
-
16603397
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,044
- Quartile Q1
- H-Index 188
- Cites/doc 6,26
- Docs (3y) 2.009
- Cites (3y) 13.938
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 5,7
- 5Y JIF 6,3
- JCI 1,22
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Drug Discovery Q1
- Pharmaceutical Science Q1
- Pharmacology, Toxicology and Pharmaceutics (miscellaneous) Q1
Areas
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Chemistry, Medicinal | Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,044 | 5,7 | 6,3 | 1,22 | Q1 | 188 |
| 2024 | Q1 | Q1 | 1,03 | 5,4 | 5,6 | 1,27 | Q1 | 174 |
| 2023 | Q1 | Q1 | 0,88 | 4,9 | 5,2 | 1,27 | Q1 | 174 |
| 2022 | Q1 | Q1 | 0,813 | 5,4 | 5,5 | 1,3 | Q1 | 174 |
| 2021 | Q1 | Q1 | 0,794 | 6,1 | 6 | 1,37 | Q1 | 174 |
| 2020 | Q2 | Q1 | 0,848 | 5,1 | 6 | 1,33 | Q1 | 174 |
| 2019 | Q2 | Q2 | 0,71 | 4,1 | 4,9 | 1,25 | Q1 | 174 |
| 2018 | — | Q1 | — | 3,8 | 4,4 | 1,19 | Q1 | — |
| 2017 | Q1 | Q1 | 0,978 | 4,4 | 4,2 | 1,2 | Q1 | 174 |
| 2016 | Q2 | Q1 | 0,883 | 3,5 | 3,6 | — | — | 174 |
| 2015 | Q2 | Q1 | 0,775 | 3,3 | 4 | — | — | 174 |
| 2014 | Q2 | Q2 | 0,78 | 2,9 | 3,9 | — | — | 174 |
| 2013 | Q2 | Q1 | 0,932 | 3,5 | 4,3 | — | — | 174 |
| 2012 | Q2 | Q1 | 0,897 | 4 | 3,9 | — | — | 174 |
| 2011 | Q1 | Q1 | 0,983 | 3,9 | 3,7 | — | — | 174 |
| 2010 | Q2 | Q1 | 0,751 | 3,5 | 3,2 | — | — | 174 |
| 2009 | — | Q2 | — | 2,9 | — | — | — | — |
| 2008 | — | Q3 | — | 1,2 | — | — | — | — |
| 2007 | — | Q3 | — | 1,1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 16/72 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 52/356 |
| 2024 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 12/72 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 38/352 |
| 2023 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 14/72 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 46/354 |
| 2022 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 13/60 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 50/278 |
| 2021 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 10/63 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 48/279 |
| 2020 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 12/62 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 60/276 |
| 2019 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q1 | 16/61 |
| 2018 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 15/61 |
| 2017 | CHEMISTRY, MEDICINAL | SCIE | Q1 | Q1 | 5/59 |
| 2016 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 13/60 |
| 2015 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 13/59 |
| 2014 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 22/59 |
| 2013 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 10/58 |
| 2012 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 6/59 |
| 2011 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 7/59 |
| 2010 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 9/54 |
| 2009 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 16/46 |
| 2008 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 28/41 |
| 2007 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 29/41 |